![]() |
市场调查报告书
商品编码
1699264
双能量 X 射线吸收法市场机会、成长动力、产业趋势分析及 2025-2034 年预测Dual-energy X-ray Absorptiometry Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 |
2024 年全球双能量 X 射线吸收仪市值为 6.567 亿美元,预计 2025 年至 2034 年期间的复合年增长率为 8.1%。 DEXA 是一种广泛使用的医学影像技术,旨在评估骨矿物质密度 (BMD) 和身体组成。其主要应用是诊断骨质疏鬆症和长期追踪骨骼健康状况。骨质疏鬆症盛行率的上升和全球人口老化是这些系统需求不断增加的关键驱动因素。由于老年人骨折风险较高且骨密度降低,早期发现和持续监测的需求日益增长。 DEXA 系统因其在评估骨折风险和测量骨骼健康方面的精确度而在医院、诊断中心和专科诊所中变得越来越普遍。对预防性医疗保健的重视和医学影像技术的进步进一步加速了市场的成长。
市场分为全轴和周边 DEXA 骨密度仪。 2024 年,轴向 DEXA 领域引领市场,创造 3.552 亿美元的收入。该领域因其在诊断骨质疏鬆症和评估臀部和脊柱等关键骨骼区域的 BMD 方面的高准确性而受到青睐。与週边系统相比,轴向 DEXA 在检测骨质疏鬆症的早期迹象和监测治疗进展方面具有更高的精度。它在运动医学和肥胖管理领域的广泛应用也有助于其占据市场主导地位。
市场范围 | |
---|---|
起始年份 | 2024 |
预测年份 | 2025-2034 |
起始值 | 6.567亿美元 |
预测值 | 14.3亿美元 |
复合年增长率 | 8.1% |
市场的另一个细分是基于产品类型,包括独立和便携式 DEXA 系统。独立部分在 2024 年占了 59.4% 的市场份额,预计到 2034 年价值将达到 8.655 亿美元。这些系统主要安装在医院、诊断中心和研究机构,在那里它们提供高成像强度和骨密度评估的准确性。它们能够提供精确的诊断并支持代谢健康评估,这使它们成为医疗机构的首选。领先的产业参与者正在整合低剂量辐射功能,以提高病患安全性,同时不影响诊断效率。
在应用方面,DEXA 市场涵盖骨质疏鬆症诊断、身体组成分析、骨折管理、骨密度测量和其他医疗用途。 2024 年,骨质疏鬆症领域创造了 2.38 亿美元的收入,由于疾病的盛行率不断上升,该领域保持领先地位。随着骨骼健康意识的增强,越来越多的患者和医疗保健提供者开始重视早期发现和常规评估。
医院和诊所成为最大的终端使用领域,到 2024 年就占了 43.5% 的市场。这些机构作为主要医疗保健提供者,进行 DEXA 扫描以准确诊断骨质疏鬆症并监测患者。这些设施中先进的医疗设备和熟练的专业人员的结合促进了这些系统的广泛应用。
美国市场收入大幅成长,2023 年达到 2.126 亿美元,预计到 2034 年将达到 4.892 亿美元。骨质疏鬆症盛行率高和骨密度测试的保险覆盖率是推动市场扩张的关键因素。
The Global Dual-Energy X-Ray Absorptiometry Market was valued at USD 656.7 million in 2024 and is projected to expand at a CAGR of 8.1% from 2025 to 2034. DEXA is a widely used medical imaging technology designed to assess bone mineral density (BMD) and body composition. Its primary application is in diagnosing osteoporosis and tracking bone health over time. The rising prevalence of osteoporosis and an aging global population are key drivers behind the increasing demand for these systems. With a higher risk of fractures and reduced BMD among older adults, the need for early detection and continuous monitoring is growing. DEXA systems are becoming more prevalent in hospitals, diagnostic centers, and specialty clinics due to their precision in evaluating fracture risks and measuring bone health. The emphasis on preventive healthcare and advancements in medical imaging technologies are further accelerating market growth.
The market is divided into total axial and peripheral DEXA bone densitometers. In 2024, the axial DEXA segment led the market, generating USD 355.2 million in revenue. This segment is favored for its high accuracy in diagnosing osteoporosis and assessing BMD in crucial skeletal regions like the hip and spine. Compared to peripheral systems, axial DEXA provides superior precision in detecting early signs of osteoporosis and monitoring treatment progress. Its extensive use in sports medicine and obesity management also contributes to its market dominance.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $656.7 Million |
Forecast Value | $1.43 Billion |
CAGR | 8.1% |
Another segmentation of the market is based on product type, which includes standalone and portable DEXA systems. The standalone segment accounted for 59.4% of the market share in 2024, with a projected value of USD 865.5 million by 2034. These systems are primarily installed in hospitals, diagnostic centers, and research institutions, where they offer high imaging strength and accuracy in bone density assessment. Their ability to provide precise diagnostics and support metabolic health evaluations makes them a preferred choice in medical facilities. Leading industry players are integrating low-dose radiation features to enhance patient safety without compromising diagnostic efficiency.
Regarding applications, the DEXA market encompasses osteoporosis diagnosis, body composition analysis, fracture management, bone densitometry, and other medical uses. The osteoporosis segment generated USD 238 million in 2024, maintaining a leading position due to the increasing prevalence of the disease. As bone health awareness grows, more patients and healthcare providers are prioritizing early detection and routine assessments.
Hospitals and clinics emerged as the top end-use segment, capturing 43.5% of the market share in 2024. These institutions serve as primary healthcare providers, conducting DEXA scans for accurate osteoporosis diagnosis and patient monitoring. The combination of advanced medical equipment and skilled professionals in these facilities contributes to the widespread adoption of these systems.
The U.S. market has seen substantial revenue growth, reaching USD 212.6 million in 2023, and is projected to hit USD 489.2 million by 2034. High osteoporosis prevalence and insurance coverage for bone density tests are key factors fueling market expansion.